XBiotech (XBIT) IPO Opens Up 21%

Go back to XBiotech (XBIT) IPO Opens Up 21%

XBiotech Announces Pricing of Initial Public Offering

April 14, 2015 5:25 PM UTC

AUSTIN, Texas, April 14, 2015 (GLOBE NEWSWIRE) -- XBiotech Inc., a leading developer of next-generation therapeutic antibodies, announced today the pricing of its initial public offering of 4,000,000 shares of its common stock at an initial public offering price of $19.00 per share for a total offering amount of $76,000,000, before the underwriting discount. The shares are expected to begin trading on the Nasdaq... More